Sep 182015
 

By Talent4Boards Team

Talent4Boards – Great Talent builds Great Boards

– USA, MA – Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of Georges Gemayel, Ph.D. to its Board of Directors effective January 1, 2016. Dr. Gemayel has over 25 years of experience in the global biopharmaceutical industry including management and executive positions at biopharmaceutical companies such as Roche Labs, Genzyme and Altus Pharmaceuticals.… => more

Momenta Pharmaceuticals welcomes Georges Gemayel to its Board of Directors

From:: Momenta Pharmaceuticals welcomes Georges Gemayel to its Board of Directors

 Posted by at 2:28 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: